{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:33:56Z","timestamp":1792564436819,"version":"4.5.0"},"reference-count":92,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The growing demand for anticancer drugs, increased drug wastage, and the chemotherapy cost are the major concerns in oncology care. The review aims to identify the various anticancer drug waste minimization strategies and the associated cost savings in hospital settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The five-stage approach of Arksey and O'Malley (2005) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews guidelines were used for the review. Keywords like \u201cdrug therapy,\u201d \u201cchemotherapy,\u201d \u201ccytotoxic drugs,\u201d \u201cwaste management,\u201d \u201cwaste reduction,\u201d \u201cdrug wastage,\u201d and \u201cwaste minimization\u201d were used in PubMed, SCOPUS, and EMBASE databases for literature search. We used the two-step screening approach for the eligible articles, which were further cross-referenced and categorized based on the methods of waste minimization and cost savings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>From the 3506 articles screened, 64 articles were identified as eligible for the review, and 12 were additionally included from cross-referencing. We identified 14 waste minimization strategies and 8 hospital programs\/protocols in which dose rounding (25%), vial sharing (18.42%), closed system transfer device, or CSTD (10.53%), and drug reuse\/recycling (10.53%) were the highest. All the studies showed waste reduction. Seventy two out of the 74 studies that used cost analysis showed cost savings as a reduction in the cost of wastage or overall economic savings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Though waste minimization strategies have been shown to have more significance on cost savings both for overall treatment and for the total cost of the drugs saved from wastage, conflicting results exist in the efficacy and cost-saving of some. These strategies in hospital settings require more attention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riag062","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:21:51Z","timestamp":1776684111000},"source":"Crossref","is-referenced-by-count":1,"title":["Waste minimization and cost-saving strategies for drug use optimization in cancer chemotherapy: a scoping review"],"prefix":"10.1093","author":[{"given":"Alan","family":"Joy","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education , Manipal 576104, Karnataka ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwetha","family":"Somakumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education , Manipal 576104, Karnataka ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya P","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education , Manipal 576104, Karnataka ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalya","family":"Vasudeva Bhat","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Kasturba Medical College, Manipal Academy of Higher Education , Manipal 576104, Karnataka ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1261-4977","authenticated-orcid":false,"given":"Vilakkathala","family":"Rajesh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education , Manipal 576104, Karnataka ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026051806133755500_ref1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1177\/1078155220901336","article-title":"Centralization impact and cost-saving study in a Moroccan hospital\u2019s centralized unit of chemotherapy preparation","volume":"26","author":"Adade","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1200\/EDBK_100028","article-title":"An arm and a leg: the rising cost of cancer drugs and impact on access","volume":"41","author":"Leighl","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026051806133755500_ref3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1078155218762596","article-title":"Financial impact of oral chemotherapy wastage on society and the patient","volume":"25","author":"Monga","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/ajhp\/zxab479","article-title":"Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system","volume":"79","author":"Shah","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"2026051806133755500_ref5","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.22034\/APJCP.2016.17.11.4951","article-title":"Cost analysis of using a closed-system transfer device (CSTD) for antineoplastic drug preparation in a Malaysian government-funded hospital","volume":"17","author":"Chan","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026051806133755500_ref6","doi-asserted-by":"publisher","first-page":"e13464","DOI":"10.1111\/ijcp.13464","article-title":"Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage","volume":"74","author":"Yamada","year":"2020","journal-title":"Int J Clin Pract"},{"key":"2026051806133755500_ref7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.6004\/jnccn.2012.0063","article-title":"Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions","volume":"10","author":"Khandelwal","year":"2012","journal-title":"J Natl Compr Cancer Netw"},{"key":"2026051806133755500_ref8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1472-6963-14-57","article-title":"Drug waste minimization as an effective strategy of cost-containment in oncology","volume":"14","author":"Fasola","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2026051806133755500_ref9","first-page":"353","article-title":"Drug vial optimization (DVO) for anti-cancer drugs","volume":"44","author":"Iwamoto","year":"2017","journal-title":"Gan To Kagaku Ryoho"},{"key":"2026051806133755500_ref10","doi-asserted-by":"publisher","first-page":"i788","DOI":"10.1136\/bmj.i788","article-title":"Overspending driven by oversized single dose vials of cancer drugs","volume":"352","author":"Bach","year":"2016","journal-title":"BMJ."},{"key":"2026051806133755500_ref11","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1111\/bcp.14064","article-title":"Cancer chemotherapy drug wastage in a tertiary care hospital in India\u2014a 3-month prospective and 1-year retrospective study","volume":"85","author":"Gopisankar","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"2026051806133755500_ref12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/13696998.2018.1467918","article-title":"Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States","volume":"21","author":"Hess","year":"2018","journal-title":"J Med Econ"},{"key":"2026051806133755500_ref13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.31557\/apjcc.2024.9.4.679-685","article-title":"Study of the excess cost associated with drug wastage due to limited vial size options of the intravenous drugs for anti-cancer treatment, among patients receiving such treatment at Tata Memorial Hospital","volume":"9","author":"Tiwari","year":"2024","journal-title":"Asian Pacific J Cancer Care"},{"key":"2026051806133755500_ref14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2217\/fon-2017-0033","article-title":"Opportunities to significantly reduce expenditure associated with cancer drugs","volume":"13","author":"Gilbar","year":"2017","journal-title":"Future Oncol"},{"key":"2026051806133755500_ref15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"2026051806133755500_ref16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026051806133755500_ref17","author":"10. Scoping Reviews [Internet]","year":"2024"},{"key":"2026051806133755500_ref18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/1078155217722205","article-title":"Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization","volume":"24","author":"Chillari","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref19","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212462439","article-title":"Rounding rituximab dose to nearest vial size","volume":"19","author":"Patel","year":"2013","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1177\/10781552211024727","article-title":"Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia","volume":"28","author":"Zacholski","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1078155219846958","article-title":"Automated parenteral chemotherapy dose-banding to improve patient safety and decrease drug costs","volume":"26","author":"Fahey","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1078155216675518","article-title":"Evaluation of the dosing strategies of biologic agents and the theoretical impact of dose rounding","volume":"24","author":"Lindsey","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1200\/OP.23.00688","article-title":"Reducing cancer drug cost: 3-year analysis of automated dose rounding in electronic health records","volume":"21","author":"Shah","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"2026051806133755500_ref24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1177\/10781552221147659","article-title":"Implications of a technician-led pharmacy service on a day case unit in a tertiary oncology centre","volume":"29","author":"Brown","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11523-023-00958-6","article-title":"A systematic evaluation of cost-saving dosing regimens for therapeutic antibodies and antibody-drug conjugates for the treatment of lung cancer","volume":"18","author":"Heine","year":"2023","journal-title":"Target Oncol"},{"key":"2026051806133755500_ref26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3747\/co.27.6041","article-title":"Update on the subcutaneous administration of rituximab in Canadian cancer centres","volume":"27","author":"Stewart","year":"2020","journal-title":"Curr Oncol"},{"key":"2026051806133755500_ref27","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.21873\/invivo.12055","article-title":"Extended stability of reconstituted lyophilized Erwinia L-asparaginase in vials","volume":"34","author":"Vi\u00f1a-Romero","year":"2020","journal-title":"In Vivo"},{"key":"2026051806133755500_ref28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.eururo.2020.09.048","article-title":"Significantly minimizing drug wastage and the cost of cabazitaxel used to treat metastatic castration-resistant prostate cancer","volume":"79","author":"Jiang","year":"2021","journal-title":"Eur Urol"},{"key":"2026051806133755500_ref29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00520-004-0606-5","article-title":"Implications of dose rounding of chemotherapy to the nearest vial size","volume":"12","author":"Dooley","year":"2004","journal-title":"Support Care Cancer"},{"key":"2026051806133755500_ref30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1472-6963-8-70","article-title":"Drug waste minimisation and cost-containment in medical oncology: two-year results of a feasibility study","volume":"8","author":"Fasola","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"2026051806133755500_ref31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1743-7563.2010.01297.x","article-title":"Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs","volume":"6","author":"Field","year":"2010","journal-title":"Asia-Pacific J Clin Oncol"},{"key":"2026051806133755500_ref32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1078155210366171","article-title":"Cost savings from dose rounding of biologic anticancer agents in adults","volume":"17","author":"Winger","year":"2011","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref33","volume-title":"FE [Internet]","author":"Ibrahim","year":"2013"},{"key":"2026051806133755500_ref34","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213476723","article-title":"Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings","volume-title":"J Oncol Pharm Pract","author":"","year":"2014"},{"key":"2026051806133755500_ref35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1078155217692400","article-title":"Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center","volume":"24","author":"Copur","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref36","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216639756","volume":"23","author":"","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref37","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214533369","volume":"21","author":"","year":"2015"},{"key":"2026051806133755500_ref38","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1177\/1078155220967981","article-title":"Organization of chemotherapeutic preparations in advance: do we save or waste money?","volume":"27","author":"Desmaris","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref39","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.3390\/cancers13235977","article-title":"The cost of enfortumab vedotin wastage due to vial size\u2014a real-world analysis","volume":"13","author":"Sarfaty","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026051806133755500_ref40","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1177\/10781552211024723","article-title":"Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: international oncology pharmacy survey","volume":"28","author":"Gilbar","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/10781552231203403","article-title":"Evaluating cost savings in cytotoxic leftover management: a prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology","volume":"30","author":"El Baraka","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1078155220929756","article-title":"A real-world data approach to determine the optimal dosing strategy for pembrolizumab","volume":"27","author":"Jang","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref43","doi-asserted-by":"publisher","first-page":"936686","DOI":"10.3389\/fpubh.2022.936686","article-title":"Cost analysis of implementing a vial-sharing strategy for chemotherapy drugs using intelligent dispensing robots in a tertiary Chinese hospital in Sichuan","volume":"10","author":"Liu","year":"2022","journal-title":"Front Public Health"},{"key":"2026051806133755500_ref44","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/10781552231178678","article-title":"Quantifying chemotherapy wastage in an ambulatory cancer centre in Singapore","volume":"30","author":"Chan","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11096-022-01388-6","article-title":"An economic evaluation of vial sharing of expensive drugs in automated compounding","volume":"44","author":"Baan","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"2026051806133755500_ref46","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1200\/JOP.19.00813","article-title":"Real-world nivolumab wastage and leftover drug stability assessment to facilitate drug vial optimization for cost savings","volume":"16","author":"Fukudo","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2026051806133755500_ref47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/1078155218755867","article-title":"Optimization of resources by drug management: a multicentred web-administered study on the use of ipilimumab in Italy","volume":"25","author":"Damuzzo","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref48","doi-asserted-by":"publisher","first-page":"e26651","DOI":"10.1002\/pbc.26651","article-title":"A cost analysis of individualized asparaginase treatment in pediatric acute lymphoblastic leukemia","volume":"64","author":"Kloos","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"2026051806133755500_ref49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/ejhpharm-2014-000547","article-title":"A 2-year retrospective review of vial sharing options for the compounding of cytotoxics","volume":"22","author":"Smith","year":"2015","journal-title":"Eur J Hosp Pharm"},{"key":"2026051806133755500_ref50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/10781552241230889","article-title":"Manual versus automated chemotherapy preparation: a retrospective pharmaco-economic analysis","volume":"31","author":"Chennaq","year":"2025","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref51","doi-asserted-by":"publisher","DOI":"10.24875\/j.gamo.23000055","article-title":"Cost reduction for cancer drug treatment with a vial sharing strategy in a centralized preparation unit [Reducci\u00f3n de costos en el tratamiento de f\u00e1rmacos contra el c\u00e1ncer mediante una estrategia de compartici\u00f3n de viales en una unidad de preparaci\u00f3n centralizada]","volume":"23","author":"Garc\u00eda-N\u00fa\u00f1ez","year":"2024","journal-title":"Gac Mex Oncol"},{"key":"2026051806133755500_ref52","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/10781552211008527","article-title":"Anticancer drug waste minimization and cost-saving study by using a closed-system transfer device for chemotherapy compounding","volume":"28","author":"Adade","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jppr.1549","article-title":"Expanding the war on waste: recycling cancer drugs","volume":"49","author":"Gilbar","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"2026051806133755500_ref54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jppr.1533","article-title":"Utility of PhaSeal, a closed-system drug transfer device, in facilitating vial sharing to reduce waste and assist in medication cost savings","volume":"49","author":"Siderov","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"2026051806133755500_ref55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10463356.2019.1573085","article-title":"Implementation of drug vial optimization to reduce drug waste","volume":"34","author":"Amerine","year":"2019","journal-title":"Oncol Issues"},{"key":"2026051806133755500_ref56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/1078155213499387","article-title":"Cost savings realized by use of the PhaSeal\u00ae closed-system transfer device for preparation of antineoplastic agents","volume":"19","author":"Edwards","year":"2013","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref57","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s40267-016-0285-6","article-title":"Responding to drug shortages and rising costs: IV chemotherapy drug use optimization achieved by closed safety devices in hospital pharmacies","volume":"32","author":"Juh\u00e1sz","year":"2016","journal-title":"Drugs Ther Perspect"},{"key":"2026051806133755500_ref58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.33393\/grhta.2021.2202","article-title":"Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital","volume":"8","author":"Chiumente","year":"2021","journal-title":"Glob Reg Health Technol Assess"},{"key":"2026051806133755500_ref59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.breast.2022.07.007","article-title":"Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer","volume":"65","author":"Leung","year":"2022","journal-title":"Breast."},{"key":"2026051806133755500_ref60","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2019.25.8.859","article-title":"Quantification of economic impact of drug wastage in oral oncology medications: comparison of 3 methods using palbociclib and ribociclib in advanced or metastatic breast cancer","volume":"25","author":"Biskupiak","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"2026051806133755500_ref61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejogrb.2017.12.006","article-title":"Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: a time, motion and cost assessment study in a lean operating day care oncology unit","volume":"221","author":"Tjalma","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026051806133755500_ref62","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.25238","article-title":"A cost saving and waste minimization study about handling of the antineoplastic agents","volume":"14","author":"Karako\u00e7","year":"2017","journal-title":"Turk J Pharm Sci"},{"key":"2026051806133755500_ref63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/CEOR.S97319","article-title":"Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin\u2019s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey","volume":"8","author":"Ponzetti","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"2026051806133755500_ref64","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v47i1.2356","article-title":"Chemotherapy waste reduction through shelf-life extension","volume":"47","author":"Walker","year":"1994","journal-title":"Can J Hosp Pharm"},{"key":"2026051806133755500_ref65","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/107815529600200308","article-title":"Economic benefit of a centralized reconstitution unit of cytotoxic drugs in isolator","volume":"2","author":"Favier","year":"1996","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/107815529800400101","article-title":"Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust","volume":"4","author":"Baker","year":"1998","journal-title":"J Oncol Pharm Pract"},{"key":"2026051806133755500_ref67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamaoncol.2023.4865","article-title":"Cost savings and waste reduction through redispensing unused oral anticancer drugs","volume":"10","author":"Smale","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026051806133755500_ref68","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.13040\/IJPSR.0975-8232.7(3).1039-42","article-title":"Therapeutic and economic benefits of a centralized unit for cytostatic drugs processing","volume":"7","author":"Shkoza","year":"2016","journal-title":"Int J Pharm Sci Res"},{"key":"2026051806133755500_ref69","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/s12913-020-05822-1","article-title":"Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital","volume":"20","author":"Matsuo","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2026051806133755500_ref70","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2146\/ajhp160254","article-title":"Minimization of olaratumab drug waste using real-world data","volume":"74","author":"Sheffield","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"2026051806133755500_ref71","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.jval.2011.05.013","article-title":"Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil","volume":"14","author":"Clark","year":"2011","journal-title":"Value Health"},{"key":"2026051806133755500_ref72","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1590\/1806-9282.61.04.368","article-title":"A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation","volume":"61","author":"Hyeda","year":"2015","journal-title":"Rev Assoc Med Bras"},{"key":"2026051806133755500_ref73","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s11096-014-9974-1","article-title":"Computer-assisted management of unconsumed drugs as a cost-containment strategy in oncology","volume":"36","author":"Respaud","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"2026051806133755500_ref74","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1200\/JCO.2007.11.2516","article-title":"Trastuzumab and metastatic breast cancer: trastuzumab use in Australia\u2014monitoring the effect of an expensive medicine access program","volume":"25","author":"Pearson","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026051806133755500_ref75","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1200\/JOP.18.00541","article-title":"Successful implementation of a multidisciplinary chemotherapy efficiency initiative at a community hospital","volume":"15","author":"Parkes","year":"2019","journal-title":"JOP."},{"key":"2026051806133755500_ref76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00130404-200207000-00010","article-title":"Implementation and results of a test dose program with taxanes","volume":"8","author":"Krieger","year":"2002","journal-title":"Cancer J"},{"key":"2026051806133755500_ref77","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1185\/030079905X65411","article-title":"A randomized trial assessing the utility of a test-dose program with taxanes","volume":"21","author":"Stanford","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"2026051806133755500_ref78","doi-asserted-by":"publisher","first-page":"djx063","DOI":"10.1093\/jnci\/djx063","article-title":"A phamacoeconomic analysis of personalized dosing vs fixed dosing of pembrolizumab in firstline PD-L1-positive non\u2013small cell lung cancer","volume":"109","author":"Goldstein","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2026051806133755500_ref79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11096-020-01131-z","article-title":"A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute","volume":"43","author":"Heinhuis","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2026051806133755500_ref80","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1093\/ajhp\/zxz233","article-title":"Optimization of intravenous immune globulin use at a comprehensive cancer center","volume":"76","author":"Figgins","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"2026051806133755500_ref81","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12032-014-0457-y","article-title":"An anticancer drug unit for the whole provincial oncologic network of Piacenza: improving safety and savings","volume":"32","author":"Mordenti","year":"2015","journal-title":"Med Oncol"},{"key":"2026051806133755500_ref82","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ejca.2012.08.025","article-title":"A practical approach to improve safety and management in chemotherapy units based on the PROCHE\u2014programme for optimisation of the chemotherapy network monitoring program","volume":"49","author":"Scott\u00e9","year":"2013","journal-title":"Eur J Cancer"},{"key":"2026051806133755500_ref83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/ejhpharm-2016-000937","article-title":"Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study","volume":"25","author":"Son","year":"2018","journal-title":"Eur J Hosp Pharm"},{"key":"2026051806133755500_ref84","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1200\/JOP.19.00069","article-title":"Estimated cost and savings in a patient management program for oral oncology medications: impact of a split-fill component","volume":"15","author":"Staskon","year":"2019","journal-title":"J Oncol Pract"},{"key":"2026051806133755500_ref85","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1200\/OP.22.00553","article-title":"Feasibility of an individualized dispensing program for patients prescribed oral anticancer drugs to prevent waste","volume":"19","author":"Smale","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2026051806133755500_ref86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11096-020-01131-z","article-title":"A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute","volume":"43","author":"Heinhuis","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2026051806133755500_ref87","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S1470-2045(16)30199-1","article-title":"National Health Service England introduces dose banding","volume":"17","author":"Mayor","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026051806133755500_ref88","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/amajethics.2022.971","article-title":"How should responsibility for proper medication disposal be shared?","volume":"24","author":"Karim-Nejad","year":"2022","journal-title":"AMA J Ethics"},{"key":"2026051806133755500_ref89","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.scp.2019.100164","article-title":"Pharmacists as environmental stewards: strategies for minimizing and managing drug waste","volume":"13","author":"Afanasjeva","year":"2019","journal-title":"Sustain Chem Pharm"},{"key":"2026051806133755500_ref90","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.scp.2021.100400","article-title":"Waste-minimising measures to achieve sustainable supply and use of medication","volume":"20","author":"Smale","year":"2021","journal-title":"Sustain Chem Pharm"},{"key":"2026051806133755500_ref91","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5863\/1551-6776-29.4.434","article-title":"Artificial intelligence opportunities to guide precision dosing strategies","volume":"29","author":"Barrett","year":"2024","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2026051806133755500_ref92","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.153","article-title":"Optimizing oncology drug dosing","volume":"96","author":"Minasian","year":"2014","journal-title":"Clin Pharmacol Ther"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag062\/68320872\/riag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag062\/68320872\/riag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:13:47Z","timestamp":1779099227000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article\/doi\/10.1093\/ijpp\/riag062\/8684844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riag062","relation":{},"ISSN":["2042-7174"],"issn-type":[{"value":"2042-7174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"riag062"}}